Provided by Tiger Trade Technology Pte. Ltd.

Lipella Pharmaceuticals Inc

0.2012
-0.0138-6.42%
Volume:5.63K
Turnover:1.18K
Market Cap:898.84K
PE:-0.11
High:0.2300
Open:0.2100
Low:0.2012
Close:0.2150
52wk High:7.31
52wk Low:0.2012
Shares:4.47M
Float Shares:4.18M
Volume Ratio:0.37
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7592
EPS(LYR):-4.7857
ROE:-361.77%
ROA:-149.95%
PB:0.60
PE(LYR):-0.04

Loading ...

Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 23, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Correspondence

Form CORRESP - Correspondence
Nov 02, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 06, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 02, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 01, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 03, 2023

Major Issues Report

Form 8-K - Current report
Mar 31, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]